Mizutani T - Search Results

1

Mizutani T. Mizutani T. Uirusu. 2004 Jun;54(1):97-105. doi: 10.2222/jsv.54.97. Uirusu. 2004. PMID: 15449910 Free article. Review. Japanese.

2

Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells.

Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Mizutani T, et al. Biochem Biophys Res Commun. 2004 Jul 9;319(4):1228-34. doi: 10.1016/j.bbrc.2004.05.107. Biochem Biophys Res Commun. 2004. PMID: 15194498 Free PMC article.

3

Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells.

Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S. Mizutani T, et al. FEBS Lett. 2004 Nov 5;577(1-2):187-92. doi: 10.1016/j.febslet.2004.10.005. FEBS Lett. 2004. PMID: 15527783 Free PMC article.

4

Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS.

Saijo M, Ogino T, Taguchi F, Fukushi S, Mizutani T, Notomi T, Kanda H, Minekawa H, Matsuyama S, Long HT, Hanh NT, Kurane I, Tashiro M, Morikawa S. Saijo M, et al. Among authors: mizutani t. J Virol Methods. 2005 May;125(2):181-6. doi: 10.1016/j.jviromet.2005.01.028. J Virol Methods. 2005. PMID: 15794988 Free PMC article.

5

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus.

Saijo M, Morikawa S, Fukushi S, Mizutani T, Hasegawa H, Nagata N, Iwata N, Kurane I. Saijo M, et al. Among authors: mizutani t. Antiviral Res. 2005 Jun;66(2-3):159-63. doi: 10.1016/j.antiviral.2005.01.003. Epub 2005 Feb 19. Antiviral Res. 2005. PMID: 15911031 Free PMC article.

6

Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.

Mizutani T, Fukushi S, Saijo M, Kurane I, Morikawa S. Mizutani T, et al. FEBS Lett. 2006 Feb 20;580(5):1417-24. doi: 10.1016/j.febslet.2006.01.066. Epub 2006 Jan 30. FEBS Lett. 2006. PMID: 16458888 Free PMC article.

7

Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.

Ishii K, Hasegawa H, Nagata N, Mizutani T, Morikawa S, Suzuki T, Taguchi F, Tashiro M, Takemori T, Miyamura T, Tsunetsugu-Yokota Y. Ishii K, et al. Among authors: mizutani t. Virology. 2006 Aug 1;351(2):368-80. doi: 10.1016/j.virol.2006.03.020. Epub 2006 May 6. Virology. 2006. PMID: 16678878 Free PMC article.

8

Mechanisms of establishment of persistent SARS-CoV-infected cells.

Mizutani T, Fukushi S, Ishii K, Sasaki Y, Kenri T, Saijo M, Kanaji Y, Shirota K, Kurane I, Morikawa S. Mizutani T, et al. Biochem Biophys Res Commun. 2006 Aug 18;347(1):261-5. doi: 10.1016/j.bbrc.2006.06.086. Epub 2006 Jun 22. Biochem Biophys Res Commun. 2006. PMID: 16808902 Free PMC article.

9

Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV.

Fukushi S, Mizutani T, Saijo M, Kurane I, Taguchi F, Tashiro M, Morikawa S. Fukushi S, et al. Among authors: mizutani t. J Med Virol. 2006 Dec;78(12):1509-12. doi: 10.1002/jmv.20732. J Med Virol. 2006. PMID: 17063504 Free PMC article.

10

[Establishment of a system for determination of emerging infectious diseases (RDV method), and its application].

Mizutani T. Mizutani T. Uirusu. 2007 Dec;57(2):217-25. doi: 10.2222/jsv.57.217. Uirusu. 2007. PMID: 18357760 Free article. Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,860 results

Search Page

Filters